Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avanos Medical's share price for the quarter that ended in Mar. 2024 was $19.91. Avanos Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 46.1 Mil. Therefore, Avanos Medical's market cap for the quarter that ended in Mar. 2024 was $917.2 Mil.
Avanos Medical's quarterly market cap
increased
from Sep. 2023 ($938.7 Mil) to Dec. 2023 ($1,035.7 Mil) but then
declined
from Dec. 2023 ($1,035.7 Mil) to Mar. 2024 ($917.2 Mil).
Avanos Medical's annual market cap
declined
from Dec. 2021 ($1,671.3 Mil) to Dec. 2022 ($1,259.1 Mil) and
declined
from Dec. 2022 ($1,259.1 Mil) to Dec. 2023 ($1,035.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avanos Medical's Enterprise Value for Today is $1,046.0 Mil.
Avanos Medical Market Cap Historical Data
The historical data trend for Avanos Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Avanos Medical's Market Cap
For the Medical Devices subindustry, Avanos Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Avanos Medical's Market Cap falls into.
Avanos Medical Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Avanos Medical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (NYSE:AVNS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Avanos Medical Market Cap Related Terms
Thank you for viewing the detailed overview of Avanos Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Avanos Medical (Avanos Medical) Business Description
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AVNS has been successfully added to your 